Literature DB >> 12473063

Decreased frequency of intracellular IFN-gamma producing T cells in whole blood preparations from patients with atopic dermatitis.

Eva Källström1, Ingrid Roscher, Annica Andreasson, Ove Bäck, Marianne van Hage-Hamsten.   

Abstract

There have been contradictory reports on the shift in the T-cell cytokine expression pattern of peripheral blood mononuclear cells from patients with atopic dermatitis (AD); more specifically the interleukin (IL)-4 and interferon (IFN)-gamma profiles. The aim of this study was to shed further light on this contradiction by measuring the intracellular cytokines IL-4 and IFN-gamma by flow cytometry on unseparated whole blood to obtain results that, as accurately as possible, reflect the situation in circulating cells in vivo. The patient group including 64 patients with AD was compared with 18 nonatopic healthy adults. The results showed that the percentage of CD4+ T cells expressing IFN-gamma was significantly decreased (P < or = 0.001), as well as the percentage expressing IL-4 (P < 0.05) in AD patients compared with healthy controls. Furthermore, in supernatants from whole blood samples stimulated with phorbol 12-myristate 13-acetate and ionomycin, production of IFN-gamma was significantly decreased, while IL-4 production remained unchanged in AD patients compared with healthy controls. We also investigated if there was a relationship between serum IgE level and Phadiatop, a screening test for atopy, vs. the levels of IL-4 and IFN-gamma, but found no correlation with either. However, there was a significant correlation between disease severity and the level of total IgE (r = 0.67, P < 0.05). In conclusion, our results support the evidence for a decreased ability of peripheral CD4+ T cells to produce IFN-gamma among AD patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12473063     DOI: 10.1034/j.1600-0625.2002.110608.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  9 in total

1.  Elevated allergen-induced IL-13 secretion predicts IgE elevation in children ages 2-5 years.

Authors:  N P Ly; Y Li; D L Sredl; D L Perkins; P W Finn; S T Weiss; D R Gold
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

2.  Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12-month follow-up study.

Authors:  V Muratov; J Lundahl; A K Ulfgren; K Elvin; I Fehrman; N Ahlborg; A Ost; N Hittel; A Saniabadi; R Löfberg
Journal:  Int J Colorectal Dis       Date:  2006-03-15       Impact factor: 2.571

3.  The disease progression in the keratin 14 IL-4-transgenic mouse model of atopic dermatitis parallels the up-regulation of B cell activation molecules, proliferation and surface and serum IgE.

Authors:  L Chen; S-X Lin; L Overbergh; C Mathieu; L S Chan
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

4.  Intracellular production of IL-2, IL-4, IFN-gamma, and TNF-alpha by peripheral blood CD3+ and CD4+ T cells in children with atopic dermatitis.

Authors:  Edyta Machura; Bogdan Mazur; Jarosław Kwiecień; Krystyna Karczewska
Journal:  Eur J Pediatr       Date:  2006-11-21       Impact factor: 3.183

5.  Persulphate challenge in female hairdressers with nasal hyperreactivity suggests immune cell, but no IgE reaction.

Authors:  Kerstin Kronholm Diab; Lennart Truedsson; Maria Albin; Jørn Nielsen
Journal:  Int Arch Occup Environ Health       Date:  2008-12-02       Impact factor: 3.015

6.  Asthma in patients with atopic dermatitis.

Authors:  Z Pourpak; H Mozaffari; M Gharagozlou; Z Daneshmandi; M Moin
Journal:  Indian J Pediatr       Date:  2008-02       Impact factor: 1.967

7.  Evaluation of Potential Disease-Mediated Drug-Drug Interaction in Patients With Moderate-to-Severe Atopic Dermatitis Receiving Dupilumab.

Authors:  John D Davis; Ashish Bansal; David Hassman; Bolanle Akinlade; Meng Li; Zhaoyang Li; Brian Swanson; Jennifer D Hamilton; A Thomas DiCioccio
Journal:  Clin Pharmacol Ther       Date:  2018-04-02       Impact factor: 6.875

8.  Prolidase deficiency, a rare inborn error of immunity, clinical phenotypes, immunological features, and proposed treatments in twins.

Authors:  Nora Alrumayyan; Drew Slauenwhite; Sarah M McAlpine; Sarah Roberts; Thomas B Issekutz; Adam M Huber; Zaiping Liu; Beata Derfalvi
Journal:  Allergy Asthma Clin Immunol       Date:  2022-02-23       Impact factor: 3.406

9.  IFN-γ Reduces Epidermal Barrier Function by Affecting Fatty Acid Composition of Ceramide in a Mouse Atopic Dermatitis Model.

Authors:  Hiroyuki Kanoh; Asako Ishitsuka; Etsuko Fujine; Shuhei Matsuhaba; Mitsuhiro Nakamura; Hiroyasu Ito; Naoki Inagaki; Yoshiko Banno; Mariko Seishima
Journal:  J Immunol Res       Date:  2019-01-29       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.